A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 16
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : F/T
Long Form : free/total
No. Year Title Co-occurring Abbreviation
2019 Prostate Cancer Risk-Associated Single-Nucleotide Polymorphism Affects Prostate-Specific Antigen Glycosylation and Its Function. KLK3, PCa, PSA, SNPs, tPSA
2018 Prognostic Value of Neutrophil to Lymphocyte Ratio on Pathologic Findings of Transrectal Ultrasonography Guided Biopsy of Prostate. PSA
2018 The Urinary Sarcosine/Creatinine Ratio is a Potential Diagnostic and Prognostic Marker in Prostate Cancer. AUC, BPH, PSA, ROC
2015 Neutrophil-to-lymphocyte ratio predicts prostatic carcinoma in men undergoing needle biopsy. NLR, PSA
2013 Prostate cancer detection rate at repeat saturation biopsy: PCPT risk calculator versus PCA3 score versus case-finding protocol. DRE, PCA3, PCPT, PSA
2011 PCA3 score vs PSA free/total accuracy in prostate cancer diagnosis at repeat saturation biopsy. ---
2009 Free PSA/total PSA ratio increases the detection rate of prostate cancer in twelve-core biopsy. PSA
2009 [Free/total PSA ratio in clinical and ambulatory application. Are different cutoffs justified?]. PSA
2006 Free/total PSA ratio can help in the prediction of high gleason score prostate cancer in men with total serum prostate specific antigen (PSA) of 3-10 ng/ml. PSA
10  2006 [Combined use of PSA density and free to total PSA ratio for cancer detection from patients with PSA elevations]. PSA, PSAD
11  2005 Urinary/serum prostate-specific antigen ratio: comparison with free/total serum prostate-specific antigen ratio in improving prostate cancer detection. PSA, U/S
12  2002 Free/total PSA ratio does not improve prediction of pathologic stage and biochemical recurrence after radical prostatectomy. PSA
13  2000 The significance of PSA/IGF-1 ratio in differentiating benign prostate hyperplasia from prostate cancer. BPH, IGF-1, PSA, ROC
14  1997 Serum free/total prostatic-specific antigen in prostate cancer patients treated with LH-RH agonists. LHRH, PSA
15  1997 [Free/total ratio of prostate-specific antigen (PSA) for prostate cancer detection in patients with gray zone PSA level]. fPSA, PSA, tPSA
16  1996 Preliminary results of clinical evaluation of the free/total prostate-specific antigen ratio in a multicentric study. PSA